Finance

Lists
Why is BFRI down 18.01%?
Dive Deeper
BFRI:NASDAQ
Biofrontera Inc
$0.57
-18.01%
(-0.13) 1D
Nov 16, 3:52:26 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BFRI...
Open
$0.70
High
$0.70
Low
$0.57
Mkt. cap
8.61M
Avg. vol.
227.70K
Volume
341.00K
52-wk high
$1.66
52-wk low
$0.55
EPS
-$0.59
Beta
0.88
Shares outstanding
14.85M
No. of employees
89
Open
$0.70
High
$0.70
Low
$0.57
Mkt. cap
8.61M
Avg. vol.
227.70K
Volume
341.00K
52-wk high
$1.66
52-wk low
$0.55
EPS
-$0.59
Beta
0.88
Shares outstanding
14.85M
No. of employees
89
News stories
From web sources and news partners
About Biofrontera Inc
CEO-
Employees89
Founded2015
HeadquartersWoburn, Massachusetts, United States
SectorHealth Care
IndustryPharmaceutical industry
Analyst
Recommendation
Action
Price target
Projected
Date
Bruce Jackson
Benchmark Co.
Buy
Maintained
$3.00
+422.6%
05/19/2026
Jonathan Aschoff
Roth MKM
Buy
Maintained
$9.00
+1,467.9%
05/15/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
17.10M
10.08M
12.00M
9.07M
Cost of goods sold
3.01M
2.12M
2.41M
2.32M
Cost of revenue
3.01M
2.12M
2.41M
2.32M
Research and development expenses
787.00K
900.00K
448.00K
450.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.74M
11.00M
9.67M
12.49M
Operating expense
9.53M
11.90M
10.12M
12.94M
Total operating expenses
12.54M
14.01M
12.53M
15.26M
Operating income
4.56M
-3.93M
-524.00K
-6.19M
Other non operating income
503.00K
-699.00K
70.00K
202.00K
EBT including unusual items
5.64M
-4.75M
-581.00K
-6.42M
EBT excluding unusual items
4.94M
-4.75M
-580.00K
-6.12M
Income tax expense
-
-
23.00K
4.00K
Effective tax rate
-
-
-3.96%
-0.06%
Other operating expenses
-
-
-
-
Net income
5.64M
-4.75M
-604.00K
-6.42M
Net profit margin
32.98%
-47.12%
-5.03%
-70.82%
Earnings per share
0.50
-0.41
-0.05
-0.42
Interest and investment income
-
-
-
-
Interest expense
-121.00K
-125.00K
-126.00K
-128.00K
Net interest expenses
-121.00K
-125.00K
-126.00K
-128.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
4.62M
-3.87M
-459.00K
-6.13M
Gain or loss from assets sale
-700.00K
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps